1 Prostacyclin Drug Market Overview 1.1 Product Overview and Scope of Prostacyclin Drug 1.2 Prostacyclin Drug Segment by Type 1.2.1 Global Prostacyclin Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Epoprostenol Sodium 1.2.3 Treprostinil 1.2.4 Iloprost 1.2.5 Beraprost Sodium 1.3 Prostacyclin Drug Segment by Application 1.3.1 Global Prostacyclin Drug Sales Comparison by Application: (2021-2027) 1.3.2 For Injection 1.3.3 For Oral 1.3.4 For Inhalation 1.4 Global Prostacyclin Drug Market Size Estimates and Forecasts 1.4.1 Global Prostacyclin Drug Revenue 2016-2027 1.4.2 Global Prostacyclin Drug Sales 2016-2027 1.4.3 Prostacyclin Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Prostacyclin Drug Market Competition by Manufacturers 2.1 Global Prostacyclin Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Prostacyclin Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Prostacyclin Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Prostacyclin Drug Manufacturing Sites, Area Served, Product Type 2.5 Prostacyclin Drug Market Competitive Situation and Trends 2.5.1 Prostacyclin Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Prostacyclin Drug Players Market Share by Revenue 2.5.3 Global Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Prostacyclin Drug Retrospective Market Scenario by Region 3.1 Global Prostacyclin Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Prostacyclin Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Prostacyclin Drug Market Facts & Figures by Country 3.3.1 North America Prostacyclin Drug Sales by Country 3.3.2 North America Prostacyclin Drug Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Prostacyclin Drug Market Facts & Figures by Country 3.4.1 Europe Prostacyclin Drug Sales by Country 3.4.2 Europe Prostacyclin Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Prostacyclin Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Prostacyclin Drug Sales by Region 3.5.2 Asia Pacific Prostacyclin Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Prostacyclin Drug Market Facts & Figures by Country 3.6.1 Latin America Prostacyclin Drug Sales by Country 3.6.2 Latin America Prostacyclin Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Prostacyclin Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Prostacyclin Drug Sales by Country 3.7.2 Middle East and Africa Prostacyclin Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Prostacyclin Drug Historic Market Analysis by Type 4.1 Global Prostacyclin Drug Sales Market Share by Type (2016-2021) 4.2 Global Prostacyclin Drug Revenue Market Share by Type (2016-2021) 4.3 Global Prostacyclin Drug Price by Type (2016-2021) 5 Global Prostacyclin Drug Historic Market Analysis by Application 5.1 Global Prostacyclin Drug Sales Market Share by Application (2016-2021) 5.2 Global Prostacyclin Drug Revenue Market Share by Application (2016-2021) 5.3 Global Prostacyclin Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 United Therapeutics 6.1.1 United Therapeutics Corporation Information 6.1.2 United Therapeutics Description and Business Overview 6.1.3 United Therapeutics Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 United Therapeutics Prostacyclin Drug Product Portfolio 6.1.5 United Therapeutics Recent Developments/Updates 6.2 Actelion (J & J) 6.2.1 Actelion (J & J) Corporation Information 6.2.2 Actelion (J & J) Description and Business Overview 6.2.3 Actelion (J & J) Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Actelion (J & J) Prostacyclin Drug Product Portfolio 6.2.5 Actelion (J & J) Recent Developments/Updates 6.3 GSK 6.3.1 GSK Corporation Information 6.3.2 GSK Description and Business Overview 6.3.3 GSK Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 GSK Prostacyclin Drug Product Portfolio 6.3.5 GSK Recent Developments/Updates 6.4 Teva 6.4.1 Teva Corporation Information 6.4.2 Teva Description and Business Overview 6.4.3 Teva Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Teva Prostacyclin Drug Product Portfolio 6.4.5 Teva Recent Developments/Updates 6.5 Toray 6.5.1 Toray Corporation Information 6.5.2 Toray Description and Business Overview 6.5.3 Toray Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Toray Prostacyclin Drug Product Portfolio 6.5.5 Toray Recent Developments/Updates 6.6 Tide Pharma 6.6.1 Tide Pharma Corporation Information 6.6.2 Tide Pharma Description and Business Overview 6.6.3 Tide Pharma Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Tide Pharma Prostacyclin Drug Product Portfolio 6.6.5 Tide Pharma Recent Developments/Updates 6.7 Bayer AG 6.6.1 Bayer AG Corporation Information 6.6.2 Bayer AG Description and Business Overview 6.6.3 Bayer AG Prostacyclin Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer AG Prostacyclin Drug Product Portfolio 6.7.5 Bayer AG Recent Developments/Updates 7 Prostacyclin Drug Manufacturing Cost Analysis 7.1 Prostacyclin Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Prostacyclin Drug 7.4 Prostacyclin Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Prostacyclin Drug Distributors List 8.3 Prostacyclin Drug Customers 9 Prostacyclin Drug Market Dynamics 9.1 Prostacyclin Drug Industry Trends 9.2 Prostacyclin Drug Growth Drivers 9.3 Prostacyclin Drug Market Challenges 9.4 Prostacyclin Drug Market Restraints 10 Global Market Forecast 10.1 Prostacyclin Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Prostacyclin Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Prostacyclin Drug by Type (2022-2027) 10.2 Prostacyclin Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Prostacyclin Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Prostacyclin Drug by Application (2022-2027) 10.3 Prostacyclin Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Prostacyclin Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Prostacyclin Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Prostacyclin Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Prostacyclin Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Prostacyclin Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Prostacyclin Drug Covered in This Study Table 5. Global Prostacyclin Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Prostacyclin Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Prostacyclin Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Prostacyclin Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Prostacyclin Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Prostacyclin Drug Manufacturing Sites and Area Served Table 11. Manufacturers Prostacyclin Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Prostacyclin Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostacyclin Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Prostacyclin Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Prostacyclin Drug Sales Market Share by Region (2016-2021) Table 17. Global Prostacyclin Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Prostacyclin Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Prostacyclin Drug Sales Market Share by Country (2016-2021) Table 20. North America Prostacyclin Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Prostacyclin Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Prostacyclin Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Prostacyclin Drug Sales Market Share by Country (2016-2021) Table 24. Europe Prostacyclin Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Prostacyclin Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Prostacyclin Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Prostacyclin Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Prostacyclin Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Prostacyclin Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Prostacyclin Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Prostacyclin Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Prostacyclin Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Prostacyclin Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Prostacyclin Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Prostacyclin Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Prostacyclin Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Prostacyclin Drug Revenue Market Share by Country (2016-2021) Table 38. Global Prostacyclin Drug Sales (K Units) by Type (2016-2021) Table 39. Global Prostacyclin Drug Sales Market Share by Type (2016-2021) Table 40. Global Prostacyclin Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Prostacyclin Drug Revenue Share by Type (2016-2021) Table 42. Global Prostacyclin Drug Price (US$/Unit) by Type (2016-2021) Table 43. Global Prostacyclin Drug Sales (K Units) by Application (2016-2021) Table 44. Global Prostacyclin Drug Sales Market Share by Application (2016-2021) Table 45. Global Prostacyclin Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Prostacyclin Drug Revenue Share by Application (2016-2021) Table 47. Global Prostacyclin Drug Price (US$/Unit) by Application (2016-2021) Table 48. United Therapeutics Corporation Information Table 49. United Therapeutics Description and Business Overview Table 50. United Therapeutics Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. United Therapeutics Prostacyclin Drug Product Table 52. United Therapeutics Recent Developments/Updates Table 53. Actelion (J & J) Corporation Information Table 54. Actelion (J & J) Description and Business Overview Table 55. Actelion (J & J) Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Actelion (J & J) Prostacyclin Drug Product Table 57. Actelion (J & J) Recent Developments/Updates Table 58. GSK Corporation Information Table 59. GSK Description and Business Overview Table 60. GSK Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. GSK Prostacyclin Drug Product Table 62. GSK Recent Developments/Updates Table 63. Teva Corporation Information Table 64. Teva Description and Business Overview Table 65. Teva Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. Teva Prostacyclin Drug Product Table 67. Teva Recent Developments/Updates Table 68. Toray Corporation Information Table 69. Toray Description and Business Overview Table 70. Toray Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Toray Prostacyclin Drug Product Table 72. Toray Recent Developments/Updates Table 73. Tide Pharma Corporation Information Table 74. Tide Pharma Description and Business Overview Table 75. Tide Pharma Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Tide Pharma Prostacyclin Drug Product Table 77. Tide Pharma Recent Developments/Updates Table 78. Bayer AG Corporation Information Table 79. Bayer AG Description and Business Overview Table 80. Bayer AG Prostacyclin Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Bayer AG Prostacyclin Drug Product Table 82. Bayer AG Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Prostacyclin Drug Distributors List Table 86. Prostacyclin Drug Customers List Table 87. Prostacyclin Drug Market Trends Table 88. Prostacyclin Drug Growth Drivers Table 89. Prostacyclin Drug Market Challenges Table 90. Prostacyclin Drug Market Restraints Table 91. Global Prostacyclin Drug Sales Forecast by Type (2022-2027) & (K Units) Table 92. Global Prostacyclin Drug Sales Market Share Forecast by Type (2022-2027) Table 93. Global Prostacyclin Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 94. Global Prostacyclin Drug Revenue Market Share Forecast by Type (2022-2027) Table 95. Global Prostacyclin Drug Sales Forecast by Application (2022-2027) & (K Units) Table 96. Global Prostacyclin Drug Sales Market Share Forecast by Application (2022-2027) Table 97. Global Prostacyclin Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 98. Global Prostacyclin Drug Revenue Market Share Forecast by Application (2022-2027) Table 99. Global Prostacyclin Drug Sales Forecast by Region (2022-2027) & (K Units) Table 100. Global Prostacyclin Drug Sales Market Share Forecast by Region (2022-2027) Table 101. Global Prostacyclin Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 102. Global Prostacyclin Drug Revenue Market Share Forecast by Region (2022-2027) Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Prostacyclin Drug Figure 2. Global Prostacyclin Drug Market Share by Type in 2020 & 2027 Figure 3. Epoprostenol Sodium Product Picture Figure 4. Treprostinil Product Picture Figure 5. Iloprost Product Picture Figure 6. Beraprost Sodium Product Picture Figure 7. Global Prostacyclin Drug Market Share by Application in 2020 & 2027 Figure 8. For Injection Figure 9. For Oral Figure 10. For Inhalation Figure 11. Global Prostacyclin Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Prostacyclin Drug Market Size 2016-2027 (US$ Million) Figure 13. Global Prostacyclin Drug Sales 2016-2027 (K Units) Figure 14. Global Prostacyclin Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Prostacyclin Drug Sales Share by Manufacturers in 2020 Figure 16. Global Prostacyclin Drug Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Prostacyclin Drug Players: Market Share by Revenue in 2020 Figure 18. Prostacyclin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Prostacyclin Drug Sales Market Share by Region (2016-2021) Figure 20. Global Prostacyclin Drug Sales Market Share by Region in 2020 Figure 21. Global Prostacyclin Drug Revenue Market Share by Region (2016-2021) Figure 22. Global Prostacyclin Drug Revenue Market Share by Region in 2020 Figure 23. United States Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. China Taiwan Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Prostacyclin Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Prostacyclin Drug by Type (2016-2021) Figure 46. Sales Market Share of Prostacyclin Drug by Application (2016-2021) Figure 47. Sales Market Share of Prostacyclin Drug by Application in 2020 Figure 48. Revenue Share of Prostacyclin Drug by Application (2016-2021) Figure 49. Revenue Share of Prostacyclin Drug by Application in 2020 Figure 50. Manufacturing Cost Structure of Prostacyclin Drug Figure 51. Manufacturing Process Analysis of Prostacyclin Drug Figure 52. Prostacyclin Drug Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

United Therapeutics Actelion (J & J) GSK Teva Toray Tide Pharma Bayer AG